Skip to content

Embodied Conversational Agents for CervicalCancer Screening Abnormalities

Embodied Conversational Agents for Cervical Cancer Screening Abnormalities

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07795385
Acronym
ECA-CCSA
Enrollment
750
Registered
2026-08-31
Start date
2026-10-01
Completion date
2029-08-15
Last updated
2026-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer Screening

Keywords

cervical cancer screening, HPV testing, colposcopy

Brief summary

Many people who receive abnormal results from cervical cancer screening do not follow up with appointments that would allow treatment of precancer and would prevent cancer. In this project, we will develop an animated health coach that works on a smartphone to guide them through the cervical cancer screening and care process to ensure they receive the follow up and treatment they need to prevent cancer.

Interventions

BEHAVIORALembodied conversational agents for cervical cancer prevention

People receiving the intervention will receive an animated health coach that works on a smartphone to guide them through the cervical cancer screening and care process to ensure they receive the follow up and treatment they need to prevent cancer.

Sponsors

Tufts Medical Center
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* age 21-65 * has an abnormal cervical cancer screening test result * able to read in English or Spanish

Exclusion criteria

* planning to move out of the study area during the follow up period * pregnant * incarcerated * dose not have adequate vision or hearing to use the app * diagnosed with cervical cancer

Design outcomes

Primary

MeasureTime frame
The proportion of participants who receive recommended follow-up testing and treatment.18 months

Contacts

CONTACTECA-CCSA Research Coordinator
saramyhealthnav@tuftsmedicine.org617-651-9410
PRINCIPAL_INVESTIGATORPerkins

Tufts Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 17, 2026